Various pharmaceutical corporations have been accused of engaging in misrepresenting the quality, safety or efficacy of their medications.
Egypt's pharmaceutical firm Ibnsina Pharma, has reportedly acquired a 75 percent stake in its compatriot 3elagi Tech.
Kuwait-based Mezzan Holding on Tuesday acquired 67 percent stake in Kuwait Saudi Pharmaceutical Industries Company (KSPICo) for $69 million.